AstraZeneca’s oncology drug star Tagrisso gets a new approval for frontline lung cancer in Japan
One of the few bright spots at AstraZeneca $AZN over the last few years has been its steady build-up of the global market for its …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
